caffeine has been researched along with Amentia in 27 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epidemiologic studies have provided inconclusive evidence for a protective effect of caffeine consumption on risk of dementia and cognitive decline." | 9.05 | Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review. ( Chen, JQA; Groot, C; Ossenkoppele, R; Scheltens, P, 2020) |
| " Studies were included when they: i) investigated patients diagnosed with dementia, ii) reported neuropsychiatric symptoms, iii) used caffeine or coffee consumption as an intervention, and iv) reported associations between caffeine or coffee consumption and neuropsychiatric symptoms." | 9.01 | Caffeine and neuropsychiatric symptoms in patients with dementia: A systematic review. ( Achterberg, WP; Giltay, E; Kromhout, MA; Numans, ME; Rius Ottenheim, N, 2019) |
| " We conducted a systematic review and meta-analysis of published studies quantifying the relation between caffeine intake and cognitive decline or dementia." | 8.86 | Caffeine intake and dementia: systematic review and meta-analysis. ( Costa, J; Lunet, N; Santos, C; Santos, J; Vaz-Carneiro, A, 2010) |
| " This review explores the relation between caffeine intake, diabetes, cognition and dementia, focusing on type 2 diabetes (T2DM)." | 8.86 | Caffeine, diabetes, cognition, and dementia. ( Biessels, GJ, 2010) |
| "Coffee, green tea, and caffeine are potential preventive factors for dementia, but the underlying evidence is insufficient." | 8.02 | Association of coffee, green tea, and caffeine with the risk of dementia in older Japanese people. ( Iki, M; Kabasawa, K; Kitamura, K; Kobayashi, R; Matsushita, N; Nakamura, K; Nakanishi, Y; Oshiki, R; Saito, T; Sasaki, A; Takachi, R; Takahashi, A; Tsugane, S; Watanabe, K; Watanabe, Y; Yamazaki, O, 2021) |
| "Caffeine is known to improve concentration and reduce fatigue in healthy adults, but high doses may induce anxiety and agitation." | 7.80 | Relation between caffeine and behavioral symptoms in elderly patients with dementia: an observational study. ( Achterberg, WP; Jongerling, J; Kromhout, MA, 2014) |
| " Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors." | 7.79 | Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. ( Costa, MS; Cunha, RA; Espinosa, J; Kalinine, E; Kazlauckas, V; Nunes, F; Porciúncula, LO; Rocha, A; Schein, V; Souza, DO, 2013) |
| " In particular, several cross-sectional and longitudinal population-based studies suggested a protective effect of coffee, tea, and caffeine use against late-life cognitive impairment/decline, although the association was not found in all cognitive domains investigated and there was a lack of a distinct dose-response association, with a stronger effect among women than men." | 6.52 | Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. ( Barulli, MR; Bonfiglio, C; Guerra, V; Logroscino, G; Osella, A; Panza, F; Pilotto, A; Sabbà, C; Seripa, D; Solfrizzi, V, 2015) |
| "Caffeine has well-known short-term stimulating effects on central nervous system, but the long-term impacts on cognition have been less clear." | 5.36 | Caffeine as a protective factor in dementia and Alzheimer's disease. ( Eskelinen, MH; Kivipelto, M, 2010) |
| "We report that performance on neuropsychological tests used in the diagnosis of dementia can be influenced by external factors such as time of day (TOD) and caffeine." | 5.20 | Time of day and caffeine influence some neuropsychological tests in the elderly. ( Lesk, VE; Walters, ER, 2015) |
| "Epidemiologic studies have provided inconclusive evidence for a protective effect of caffeine consumption on risk of dementia and cognitive decline." | 5.05 | Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review. ( Chen, JQA; Groot, C; Ossenkoppele, R; Scheltens, P, 2020) |
| "This paper reports the results of a double blind study in patients with senile dementia to determine if the quality and quantity of sleep could be changed with various amounts of caffeine." | 5.04 | Caffeine in the "sundown syndrome." Report of negative results. ( Ginsburg, R; Weintraub, M, 1976) |
| " Studies were included when they: i) investigated patients diagnosed with dementia, ii) reported neuropsychiatric symptoms, iii) used caffeine or coffee consumption as an intervention, and iv) reported associations between caffeine or coffee consumption and neuropsychiatric symptoms." | 5.01 | Caffeine and neuropsychiatric symptoms in patients with dementia: A systematic review. ( Achterberg, WP; Giltay, E; Kromhout, MA; Numans, ME; Rius Ottenheim, N, 2019) |
| "Observational epidemiological studies such as cross-sectional, case-control, and cohort studies have reported inconsistent findings regarding the association between caffeine intake from coffee or tea and the risk of cognitive disorders such as dementia, Alzheimer's disease, cognitive impairment, and cognitive decline." | 4.91 | Caffeine intake from coffee or tea and cognitive disorders: a meta-analysis of observational studies. ( Kim, YS; Kwak, SM; Myung, SK, 2015) |
| " We conducted a systematic review and meta-analysis of published studies quantifying the relation between caffeine intake and cognitive decline or dementia." | 4.86 | Caffeine intake and dementia: systematic review and meta-analysis. ( Costa, J; Lunet, N; Santos, C; Santos, J; Vaz-Carneiro, A, 2010) |
| " This review explores the relation between caffeine intake, diabetes, cognition and dementia, focusing on type 2 diabetes (T2DM)." | 4.86 | Caffeine, diabetes, cognition, and dementia. ( Biessels, GJ, 2010) |
| "Coffee, green tea, and caffeine are potential preventive factors for dementia, but the underlying evidence is insufficient." | 4.02 | Association of coffee, green tea, and caffeine with the risk of dementia in older Japanese people. ( Iki, M; Kabasawa, K; Kitamura, K; Kobayashi, R; Matsushita, N; Nakamura, K; Nakanishi, Y; Oshiki, R; Saito, T; Sasaki, A; Takachi, R; Takahashi, A; Tsugane, S; Watanabe, K; Watanabe, Y; Yamazaki, O, 2021) |
| "Caffeine is known to improve concentration and reduce fatigue in healthy adults, but high doses may induce anxiety and agitation." | 3.80 | Relation between caffeine and behavioral symptoms in elderly patients with dementia: an observational study. ( Achterberg, WP; Jongerling, J; Kromhout, MA, 2014) |
| " Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors." | 3.79 | Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. ( Costa, MS; Cunha, RA; Espinosa, J; Kalinine, E; Kazlauckas, V; Nunes, F; Porciúncula, LO; Rocha, A; Schein, V; Souza, DO, 2013) |
| "To examine the association between caffeine intake, cognitive decline, and incident dementia in a community-based sample of subjects aged 65 years and over." | 3.74 | The neuroprotective effects of caffeine: a prospective population study (the Three City Study). ( Ancelin, ML; Barberger-Gateau, P; Carrière, I; Dartigues, JF; de Mendonca, A; Portet, F; Ritchie, K; Rouaud, O, 2007) |
| " In particular, several cross-sectional and longitudinal population-based studies suggested a protective effect of coffee, tea, and caffeine use against late-life cognitive impairment/decline, although the association was not found in all cognitive domains investigated and there was a lack of a distinct dose-response association, with a stronger effect among women than men." | 2.52 | Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. ( Barulli, MR; Bonfiglio, C; Guerra, V; Logroscino, G; Osella, A; Panza, F; Pilotto, A; Sabbà, C; Seripa, D; Solfrizzi, V, 2015) |
| "Caffeine intake was determined according to self-reported coffee, tea, and cola consumption at baseline." | 1.37 | Coffee intake in midlife and risk of dementia and its neuropathologic correlates. ( Gelber, RP; Masaki, KH; Petrovitch, H; Ross, GW; White, LR, 2011) |
| "Caffeine has well-known short-term stimulating effects on central nervous system, but the long-term impacts on cognition have been less clear." | 1.36 | Caffeine as a protective factor in dementia and Alzheimer's disease. ( Eskelinen, MH; Kivipelto, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 20 (74.07) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Matsushita, N | 1 |
| Nakanishi, Y | 1 |
| Watanabe, Y | 1 |
| Kitamura, K | 1 |
| Kabasawa, K | 1 |
| Takahashi, A | 1 |
| Saito, T | 1 |
| Kobayashi, R | 1 |
| Takachi, R | 1 |
| Oshiki, R | 1 |
| Tsugane, S | 1 |
| Iki, M | 1 |
| Sasaki, A | 1 |
| Yamazaki, O | 1 |
| Watanabe, K | 1 |
| Nakamura, K | 1 |
| Kromhout, M | 3 |
| Chen, JQA | 1 |
| Scheltens, P | 1 |
| Groot, C | 1 |
| Ossenkoppele, R | 1 |
| Kromhout, MA | 3 |
| van Eijk, M | 1 |
| Pieper, MJC | 1 |
| Chel, VGM | 1 |
| Achterberg, WP | 3 |
| Numans, ME | 2 |
| Dominguez, LJ | 1 |
| Barbagallo, M | 1 |
| Park, J | 1 |
| Han, JW | 1 |
| Lee, JR | 1 |
| Byun, S | 1 |
| Suh, SW | 1 |
| Kim, T | 1 |
| Yoon, IY | 1 |
| Kim, KW | 1 |
| Gilbert, N | 1 |
| Rius Ottenheim, N | 1 |
| Giltay, E | 1 |
| Carroll, VS | 1 |
| Jongerling, J | 1 |
| Beydoun, MA | 1 |
| Beydoun, HA | 1 |
| Gamaldo, AA | 1 |
| Teel, A | 1 |
| Zonderman, AB | 1 |
| Wang, Y | 1 |
| Walters, ER | 1 |
| Lesk, VE | 1 |
| Kim, YS | 1 |
| Kwak, SM | 1 |
| Myung, SK | 1 |
| Panza, F | 1 |
| Solfrizzi, V | 1 |
| Barulli, MR | 1 |
| Bonfiglio, C | 1 |
| Guerra, V | 1 |
| Osella, A | 1 |
| Seripa, D | 1 |
| Sabbà, C | 1 |
| Pilotto, A | 1 |
| Logroscino, G | 1 |
| Golden, LE | 1 |
| Sassoon, P | 1 |
| Cáceda, R | 1 |
| Soraoka, H | 1 |
| Oniki, K | 1 |
| Matsuda, K | 1 |
| Ono, T | 1 |
| Taharazako, K | 1 |
| Uchiyashiki, Y | 1 |
| Kamihashi, R | 1 |
| Kita, A | 1 |
| Takashima, A | 1 |
| Nakagawa, K | 1 |
| Yasui-Furukori, N | 1 |
| Kadowaki, D | 1 |
| Miyata, K | 1 |
| Saruwatari, J | 1 |
| Morris, MC | 1 |
| Santos, C | 1 |
| Costa, J | 1 |
| Santos, J | 1 |
| Vaz-Carneiro, A | 1 |
| Lunet, N | 1 |
| Biessels, GJ | 1 |
| Eskelinen, MH | 1 |
| Kivipelto, M | 1 |
| Gelber, RP | 1 |
| Petrovitch, H | 1 |
| Masaki, KH | 1 |
| Ross, GW | 1 |
| White, LR | 1 |
| Cao, C | 1 |
| Loewenstein, DA | 1 |
| Lin, X | 1 |
| Zhang, C | 1 |
| Wang, L | 1 |
| Duara, R | 1 |
| Wu, Y | 1 |
| Giannini, A | 1 |
| Bai, G | 1 |
| Cai, J | 1 |
| Greig, M | 1 |
| Schofield, E | 1 |
| Ashok, R | 1 |
| Small, B | 1 |
| Potter, H | 1 |
| Arendash, GW | 1 |
| Espinosa, J | 1 |
| Rocha, A | 1 |
| Nunes, F | 1 |
| Costa, MS | 1 |
| Schein, V | 1 |
| Kazlauckas, V | 1 |
| Kalinine, E | 1 |
| Souza, DO | 1 |
| Cunha, RA | 1 |
| Porciúncula, LO | 1 |
| Ritchie, K | 1 |
| Carrière, I | 1 |
| de Mendonca, A | 1 |
| Portet, F | 1 |
| Dartigues, JF | 1 |
| Rouaud, O | 1 |
| Barberger-Gateau, P | 1 |
| Ancelin, ML | 1 |
| Schelling, JL | 1 |
| Ginsburg, R | 1 |
| Weintraub, M | 1 |
| Kaiser, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Vitamin D Status and Intakes and Their Association With Cognitive Trajectory in a Longitudinal Study of Urban Adults[NCT03320109] | 3,720 participants (Actual) | Observational | 2004-08-18 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for caffeine and Amentia
| Article | Year |
|---|---|
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review.
Topics: Caffeine; Coffee; Cognitive Dysfunction; Dementia; Humans; Protective Factors; Sex Factors; Tea | 2020 |
Nutritional prevention of cognitive decline and dementia.
Topics: Antioxidants; Autophagy; Caffeine; Catechin; Central Nervous System Stimulants; Chocolate; Cognitive | 2018 |
Caffeine and neuropsychiatric symptoms in patients with dementia: A systematic review.
Topics: Apathy; Caffeine; Dementia; Humans; Motor Skills; Nursing Homes; Randomized Controlled Trials as Top | 2019 |
Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis.
Topics: Alcohol Drinking; Alzheimer Disease; Antioxidants; Caffeine; Cognition; Cognition Disorders; Dementi | 2014 |
Caffeine intake from coffee or tea and cognitive disorders: a meta-analysis of observational studies.
Topics: Alzheimer Disease; Caffeine; Case-Control Studies; Coffee; Cognition Disorders; Cohort Studies; Deme | 2015 |
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.
Topics: Alzheimer Disease; Caffeine; Coffee; Cognition; Cognition Disorders; Cognitive Dysfunction; Dementia | 2015 |
Caffeine intake and dementia: systematic review and meta-analysis.
Topics: Caffeine; Case-Control Studies; Central Nervous System Stimulants; Cohort Studies; Cross-Sectional S | 2010 |
Caffeine, diabetes, cognition, and dementia.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Coffee; Cognition Disorders; Dementia; Diabete | 2010 |
[Therapy of sleep disorders in old age].
Topics: Age Factors; Butyrophenones; Caffeine; Cardiac Glycosides; Cerebrovascular Disorders; Chlormethiazol | 1972 |
2 trials available for caffeine and Amentia
| Article | Year |
|---|---|
Time of day and caffeine influence some neuropsychological tests in the elderly.
Topics: Aged; Alzheimer Disease; Caffeine; Circadian Rhythm; Dementia; Female; Humans; Male; Neuropsychologi | 2015 |
Caffeine in the "sundown syndrome." Report of negative results.
Topics: Aged; Caffeine; Clinical Trials as Topic; Dementia; Humans; Placebos; Sleep | 1976 |
16 other studies available for caffeine and Amentia
| Article | Year |
|---|---|
Association of coffee, green tea, and caffeine with the risk of dementia in older Japanese people.
Topics: Adult; Aged; Beverages; Caffeine; Coffee; Cohort Studies; Dementia; Diet Surveys; Female; Follow-Up | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
Topics: Caffeine; Dementia; Humans; Problem Behavior | 2021 |
BeCaf study: caffeine and behaviour in nursing homes, a study protocol and EBM training program.
Topics: Aged; Caffeine; Clinical Protocols; Cohort Studies; Curriculum; Dementia; Diabetes Mellitus; Educati | 2018 |
Lifetime coffee consumption, pineal gland volume, and sleep quality in late life.
Topics: Aged; Aged, 80 and over; Caffeine; Coffee; Cognition; Dementia; Female; Humans; Imaging, Three-Dimen | 2018 |
The science of tea's mood-altering magic.
Topics: Adenosine; Affect; Alpha Rhythm; Animals; Antioxidants; Behavior; Beta Rhythm; Blood-Brain Barrier; | 2019 |
In praise of coffee ... and caffeine.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Coffee; Dementia; Humans; Mice; Neoplasms; Spe | 2013 |
Relation between caffeine and behavioral symptoms in elderly patients with dementia: an observational study.
Topics: Aged, 80 and over; Anxiety; Apathy; Behavioral Symptoms; Caffeine; Dementia; Female; Humans; Male; M | 2014 |
A case report of late onset psychosis with dementia and aspirin and caffeine addiction.
Topics: Age of Onset; Aspirin; Caffeine; Central Nervous System Agents; Dementia; Diagnosis, Differential; H | 2015 |
The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.
Topics: Adult; Arylamine N-Acetyltransferase; Behavior; Caffeine; Cytochrome P-450 Enzyme System; Dementia; | 2016 |
Caffeine Intake and Dementia Risk-A Health Benefit From One of Life's Simple Pleasures?
Topics: Caffeine; Dementia; Humans; Pleasure; Risk Factors | 2016 |
Caffeine as a protective factor in dementia and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Coffe | 2010 |
Coffee intake in midlife and risk of dementia and its neuropathologic correlates.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Asian; Brain; Caffeine; Case-Control Studie | 2011 |
High Blood caffeine levels in MCI linked to lack of progression to dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caffeine; Case-Control Studies; Cognition; Cognitive Dys | 2012 |
Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Caffeine; Dementia; Disease Models, Animal; Hippoc | 2013 |
The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
Topics: Aged; Aged, 80 and over; Agnosia; AIDS Arteritis, Central Nervous System; Amyloid beta-Peptides; Caf | 2007 |
[Drug treatment of cerebral disorders in senility].
Topics: Aged; Alzheimer Disease; Amphetamines; Biotransformation; Caffeine; Dementia; Humans; Middle Aged; V | 1982 |